Researchers investigating beneficial new uses for psychedelic drugs have set their sights on what may seem an unlikely group of volunteer subjects — your local priest, minister or rabbi.
Scientists at New York University and Johns Hopkins University have already shown positive results in an expanding program where psychotherapists have used psilocybin, the active ingredient in “magic mushrooms,” to treat depression and acute anxiety in cancer patients.
Read Full Article »